ICD-10 Code Z13.1: Encounter for screening for diabetes mellitus

Key takeaways

ICD-10 Code Z13.1 describes an encounter for screening for diabetes mellitus in an asymptomatic patient with no confirmed diabetes diagnosis.

Z13.1 is a billable ICD-10-CM code effective October 1, 2025 (FY2026) and valid for HIPAA-covered claim submission.

Never use Z13.1 when diabetes is already diagnosed. Switch to E11.9 or the E-code that matches the confirmed type.

Once screening confirms prediabetes, the encounter takes R73.03, and R73.09 is reserved for a non-specific abnormal glucose finding.

Practice management software like Pabau validates ICD-10 entry inside the billing workflow, which cuts Z13.1 coding errors before submission.

ICD-10 Code Z13.1 is the billable ICD-10-CM code for an encounter for screening for diabetes mellitus.

It covers exactly one situation: an asymptomatic patient with no confirmed diabetes diagnosis presenting for a preventive glucose or HbA1c test. The screening intent has to be stated in the note, and the problem list has to be clear of E10.x, E11.x and E13.x.

Once a diabetes diagnosis sits in the record, the encounter becomes management rather than screening, and Z13.1 no longer applies. The sections below cover the Z13.1 versus E11.9 decision and the documentation payers look for. They also cover the tests that pair with the code and the errors that trigger denials.

ICD-10 Code Z13.1: Definition and code overview

ICD-10 Code Z13.1 is the ICD-10-CM diagnosis code for “encounter for screening for diabetes mellitus.” It belongs to the Z13 category, which covers encounters for screening for other disorders. The code describes a preventive, asymptomatic encounter whose explicit purpose is testing for undiagnosed diabetes.

The CDC/NCHS ICD-10-CM tool lists Z13.1 as a billable, specific code for fiscal year 2026. It is valid for HIPAA-covered transactions, with an effective date of October 1, 2025.

Z13.1 carries a fourth character, so it holds specificity that the parent code Z13 does not. That fourth character is what makes it submittable on a claim. It designates one clinical scenario: a patient without a known diabetes diagnosis presenting for a screening test.

The Z13 category also carries an Excludes1 note for diagnostic examinations. If a sign or symptom prompted the test, the coder reports that sign or symptom and no screening code at all.

When Z13.1 applies to a screening encounter

Z13.1 applies when the encounter has one purpose: screening an asymptomatic patient for diabetes mellitus. The U.S. Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who are overweight or obese.

That covers a wide slice of the primary care panel, so the code comes up often in annual wellness visits.

Use Z13.1 in the following clinical scenarios:

• A patient with no prior diabetes diagnosis presents for routine preventive screening as part of an annual wellness visit
• A provider orders a fasting glucose or HbA1c test specifically to screen for undiagnosed diabetes in an asymptomatic patient
• A patient at elevated risk from obesity, family history or gestational diabetes is screened before any diagnosis is confirmed
• A preventive care visit includes diabetes screening as one component of a broader metabolic panel for an asymptomatic individual
• Prediabetes screening is conducted before any elevated glucose result is returned or confirmed

Z13.1 does not apply when the patient already has a confirmed diabetes diagnosis. It also does not apply to a management or monitoring visit, or to the evaluation of a known elevated glucose. Those encounters take a diagnosis code instead: E11.x for type 2, E10.x for type 1, or R73.09 for a non-specific abnormal glucose finding.

Z13.1 vs E11.9: How to choose the right code

The Z13.1 versus E11.9 decision is the most common source of confusion in diabetes coding. The rule itself is short. Z13.1 covers screening where no diagnosis exists yet, and E11.9 covers a confirmed case of type 2 diabetes. Coders run into trouble when a screening result comes back positive during the same encounter.

When a screening encounter produces a new diabetes diagnosis at the same visit, ICD-10-CM guidelines sequence the confirmed code as principal. Z13.1 may still be reported as an additional code, depending on payer policy. Check the payer’s local coverage determination before you submit.

In practice the decision comes down to three checks, run in order, before the claim goes out.

Documentation requirements for diabetes mellitus screening

Incomplete documentation is the leading trigger for Z13.1 denials. The record has to establish that the encounter was a preventive screening visit rather than a diagnostic or management visit.

The following elements must be present in the clinical record to support Z13.1:

• Screening intent explicitly stated: the note must name the encounter purpose as preventive screening for diabetes mellitus. Evaluation of symptoms or management of an existing condition does not qualify
• No prior diabetes diagnosis on record: the chart must confirm the patient carries no existing ICD-10-CM E10.x, E11.x or E13.x diagnosis
• Patient demographics and risk factors: document age, BMI or weight status, family history, or the other USPSTF-aligned risk factors that prompted the screening order
• Ordering clinician: the ordering provider’s name and credentials must appear in the record
• Test ordered: name the screening test in the order, or give its procedure code. The options are fasting plasma glucose, HbA1c, or a two-hour plasma glucose during an oral glucose tolerance test
• No active symptoms: document that the patient is asymptomatic. Polyuria, polydipsia or unintended weight loss shifts the encounter from screening to evaluation

Some payers also want the USPSTF Grade B recommendation referenced, or the risk stratification criteria documented explicitly. Review the local coverage determination (LCD) for your Medicare Administrative Contractor before you submit a Z13.1 claim.

CPT and HCPCS codes that pair with Z13.1

Z13.1 is a diagnosis code, so it never travels alone. It is submitted alongside a procedure code describing the screening test performed, and the pairing has to reflect what happened in the encounter.

Payer acceptance of specific pairings varies, so verify against the applicable LCD or national coverage determination (NCD) first.

G0438 and G0439 are HCPCS Level II codes rather than CPT codes. That distinction matters because payer edits often check the two code sets separately. If you are pairing Z13.1 with a G code, confirm the descriptor against the current HCPCS codes list rather than a CPT book.

CPT 82947 and 83036 are the pairings AAPC describes as most common in practice. Payer coverage rules still vary, so confirm them against current LCDs before submission. Not all payers reimburse a standalone HbA1c as a screening test outside Medicare, and some require a two-hour glucose tolerance test instead.

Related ICD-10 codes and the Z13 screening category

Z13.1 sits inside the Z13 parent category, which covers screening encounters for a range of conditions. Knowing the sibling codes helps coders pick the most precise one and avoid incorrect substitutions. The AAPC ICD-10-CM code lookup lists the full Z13 category with all sibling codes.

Common coding errors to avoid with Z13.1

Z13.1 errors fall into a small number of recurring patterns. Most come from applying the code to management or evaluation visits rather than preventive screening encounters.

• Using Z13.1 when diabetes is already diagnosed: the most consequential error. If the patient carries a current diabetes diagnosis, Z13.1 is never appropriate. Using it misrepresents the encounter.
• Failing to document screening intent: the claim needs the note to say the visit was preventive screening. Without that line, payers may read the encounter as diagnostic and deny it.
• Coding Z13.1 for monitoring visits: HbA1c testing in a patient known to have diabetes is a management test. Z13.1 does not apply, whatever test was ordered.
• Omitting the companion procedure code: Z13.1 cannot be submitted alone. The claim needs the code for the specific screening test performed, such as 83036 for an HbA1c.
• Coding Z13.1 when symptoms are present: polyuria, polydipsia or unexplained weight loss shifts the encounter from screening to evaluation. Report the symptom or evaluation code instead.
• Using parent code Z13 instead of Z13.1: Z13 is a non-billable category header. Submitting it without the fourth character will get the claim rejected.

Build a pre-submission audit step that flags any Z13.1 claim where the patient also carries an active E11.x or E10.x code. Catching the conflict before the claim leaves the practice is far cheaper than appealing the denial afterward.

Z13.1 coding guidelines for FY2026

ICD-10-CM Official Guidelines for Coding and Reporting govern every Z13.1 claim submitted on or after October 1, 2025. CMS and CDC publish them jointly. The CMS ICD-10 codes page hosts the current tabular list and the guideline documents.

Key guidelines applicable to Z13.1:

• Screening codes in the Z11 to Z13 range apply to asymptomatic individuals with no known diagnosis. The screening intent must be clear in the documentation.
• When a screening exam reveals an abnormal finding, that finding may be coded as an additional code. Z13.1 stays first-listed if no definitive diagnosis is confirmed at the encounter.
• If screening confirms a condition during the same encounter, the condition code replaces Z13.1 as principal. Z13.1 may be retained as a secondary code, depending on payer guidance.
• The Z13 Excludes1 note blocks a screening code on any encounter prompted by a sign or symptom. That encounter is a diagnostic exam, so the sign or symptom is coded instead.
• Z13.1 itself did not change for FY2026. It carries the same descriptor and specificity as the FY2025 version.

How practice management software supports accurate Z13.1 coding

Coding accuracy for Z13.1 rests on two things: documentation quality at the point of care, and billing validation before the claim goes out. Both break down when they run on manual handoffs and shared spreadsheets.

Practice management software like Pabau closes the distance between the provider’s note and the biller’s code selection. Its medical claims management tools let ICD-10 entry happen inside the clinical workflow, so the code is chosen while the encounter is still fresh.

Claims carrying Z13.1 are then validated against payer rules before submission, which catches diagnosis conflicts and missing procedure companions.

When Pabau is connected to a clearinghouse such as Claim.MD, that validation runs before the claim ever reaches the payer. For practices screening across several providers or locations, it cuts per-claim review time and keeps documentation standards consistent across the team.

Reduce coding errors with smarter billing workflows

Pabau’s claims management tools help primary care and metabolic health practices submit cleaner ICD-10 claims, track denials, and keep documentation audit-ready. See how it works for your team.

Book a demo

Conclusion

Getting Z13.1 right is less about the code than about what sits around it. The disqualifier lives in the patient’s problem list, not in the order the coder is looking at. A coder reading only the test order sees a screening test and codes it as one.

So the fix is structural rather than educational. A validation rule that checks the active diagnosis list before submission will catch the conflict every time, where a coder’s memory will not. The same rule protects the two codes that take over after the result, R73.03 and E11.9.

Pabau gives primary care and metabolic health practices that validation step inside the billing workflow, along with denial tracking when a claim comes back. Book a demo to see how it handles preventive screening claims for your practice.

Continue your research

Need a reference for managing claims across multiple ICD-10 codes? What is medical billing covers the end-to-end process from code entry to claim payment.

Wondering which test code to pair with a screening encounter? CPT code 83036 covers the HbA1c test most often ordered alongside Z13.1.

Billing a Medicare annual wellness visit with the screening? HCPCS code G0438 explains what the initial wellness visit has to include.

Want to understand how clearinghouse validation reduces denials? Claim.MD vs Office Ally breaks down how clearinghouse options differ for US practices.

Looking for guidance on ICD-10 documentation compliance? Medical billing compliance outlines the documentation and audit requirements for preventive coding encounters.

Frequently asked questions